Lung protective ventilation in ARDS: Role of mediators, PEEP and surfactant

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 59, Issue 2, 2003, Pages 108-118

  Haitsma, J J ^a   Lachmann, R A ^a   Lachmann, B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ARDS; Cytokines; Mechanical ventilation; PEEP; Recruitment; Surfactant

Indexed keywords

ADENOSINE; AUTACOID; BIOCHEMICAL MARKER; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GELATINASE B; HYPOXANTHINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LUNG SURFACTANT; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PENTETATE TECHNETIUM TC 99M; PROTEIN; PROTEIN C FOS; PROTEIN C JUN; PROTEINASE; PURINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; XANTHINE;

ACUTE DISEASE; ARTIFICIAL VENTILATION; CLINICAL PRACTICE; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; INHALATION; INTENSIVE CARE; LUNG INJURY; LUNG VENTILATION; MORTALITY; NEUTROPHIL; NONHUMAN; PHYSIOLOGY; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; RESPIRATORY DISTRESS SYNDROME; REVIEW; TIDAL VOLUME; TREATMENT OUTCOME;

EID: 0242574318     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
3. Von Neergaard K. Neue Auffassungen über einen Grundbegriff der Atemmechanik; Die Retraktionskraft der Lunge, abhängig von der Oberflächenspannung in den Alveolen. Z Ges Exp Med 1929; 66: 373-394.
4. Lachmann B. The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL, editor. Update in Intensive Care and Emergency Medicine. Berlin Heidelberg: Springer-Verlag; 1987. p. 123-134.
5. Tobin MJ. Advances in mechanical ventilation. N Engl J Med, 2001; 344: 1986-1996.
6. Tobin MJ. Mechanical ventilation. N Engl J Med 1994; 330: 1056-1061.
7. Lachmann B, Jonson B, Lindroth M, Robertson B. Modes of artificial ventilation in severe respiratory distress syndrome. Lung function and morphology in rabbits after wash-out of alveolar surfactant. Crit Care Med 1982; 10: 724-732.
8. Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M. Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 1987; 136: 730-736.
9. International Consensus Conferences in Intensive Care Medicine: Ventilator-associated lung injury in ARDS. Am J Respir Crit Care Med 1999; 160: 2118-2124.
10. Mead J, Takishima T, Leith D. Stress distribution in lungs: A model of pulmonary elasticity. J Appl Physiol 1970; 28: 596-608.
11. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149: 1327-1334.
12. Taskar V, John J, Evander E, Robertson B, Jonson B. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med 1997; 155: 313-320.
13. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure. Am Rev Respir Dis 1974; 110: 556-565.
14. Verbrugge SJ, Bohm SH, Gommers D, Zimmerman LJ, Lachmann B. Surfactant impairment after mechanical ventilation with large alveolar surface area changes and effects of positive end-expiratory pressure. Br J Anaesth 1998; 80: 360-364.
15. Dreyfuss D, Saumon G. Ventilator-induced lung injury: Lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323.
16. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137: 1159-1164.
17. Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol 1989; 66: 2364-2368.
18. Coker PJ, Hernandez LA, Peevy KJ, Adkins K, Parker JC. Increased sensitivity to mechanical ventilation after surfactant inactivation in young rabbit lungs. Crit Care Med 1992; 20: 635-640.
19. Dreyfuss D, Soler P, Saumon G. Mechanical ventilation-induced pulmonary edema. Interaction with previous lung alterations. Am J Respir Crit Care Med 1995; 151: 1568-1575.
20. Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 1807-1814.
21. Hartog A, Vazquez De Anda GF, Gommers D, Kaisers U, Lachmann B. At surfactant deficiency, application of "the open lung concept" prevents protein leakage and attenuates changes in lung mechanics. Crit Care Med 2000; 28: 1450-1454.
22. Wauer R, Lachmann B. Ventilette - An emergency respirator for newborn infants and infants - Report on a trial. Padiatr Grenzgeb 1972; 11: 411-422.
23. Wyszogrodski I, Kyei-Aboagye K, Taeusch HW, Jr., Avery ME. Surfactant inactivation by hyperventilation: Conservation by end-expiratory pressure. J Appl Physiol 1975; 38: 461-466.
24. Veldhuizen RA, Marcou, J. Yao LJ, McCaig L, Ito Y, Lewis JF. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol 1996; 270: L152-158.
25. Veldhuizen RA, Inchley K, Hearn SA, Lewis JF, Possmayer F. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J 1993; 295: 141-147.
26. Haitsma JJ, Uhlig S, Goggel R, Verbrugge SJ, Lachmann U, Lachmann B. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med 2000; 26: 1515-1522.
27. Faridy EE. Effect of ventilation on movement of surfactant in airways. Respir Physiol 1976; 27: 323-334.
28. Houmes R-J, Bos JAH, Lachmann B. Effects of different ventilator settings on lung mechanics: With special reference to the surfactant system. Appl Cardiopulm Pathophysiol 1994; 5: 117-127.
29. Lachmann B, Eijking EP, So KL, Gommers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994; 20: 6-11.
30. Seeger W, Stohr G, Wolf HR, Neuhof H. Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer. J Appl Physiol 1985; 58: 326-338.
31. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991; 29: 353-356.
32. Argiras EP, Blakeley CR, Dunnill MS, Otremski S, Sykes MK. High PEEP decreases hyaline membrane formation in surfactant deficient lungs. Br J Anaesth 1987; 59: 1278-1285.
33. Sandhar BK, Niblett DJ, Argiras EP, Dunnill MS, Sykes MK. Effects of positive end-expiratory pressure on hyaline membrane formation in a rabbit model of the neonatal respiratory distress syndrome. Intensive Care Med 1988; 14: 538-546.
34. Corbridge TC, Wood LD, Crawford GP, Chudoba MJ, Yanos J, Sznajder JI. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990; 142: 311-315.
35. Bshouty Z, Ali J, Younes M. Effect of tidal volume and PEEP on rate of edema formation in in situ perfused canine lobes. J Appl Physiol 1988; 64: 1900-1907.
36. Evander E, Wollmer P, Jonson B, Lachmann B. Pulmonary clearance of inhaled 99mTc-DTPA: Effects of surfactant depletion by lung lavage. J Appl Physiol 1987; 62: 1611-1614.
37. Jefferies AL, Kawano T, Mori S, Burger R. Effect of increased surface tension and assisted ventilation on 99m-Tc-DTPA clearance. J Appl Physiol 1988; 64: 562-568.
38. Bos JA, Wollmer P, Bakker W, Hannappel E, Lachmann B. Clearance of 99mTc-DTPA and experimentally increased alveolar surfactant content. J Appl Physiol 1992; 72: 1413-1417.
39. Verbrugge SJ, Vazquez De Anda G, Gommers D, Neggers SJ, Sorm V, Bohm SH, Lachmann B. Exogenous surfactant preserves lung function and reduces alveolar Evans blue dye influx in a rat model of ventilation-induced lung injury. Anesthesiology 1998; 89: 467-474.
40. Van Rozendaal BA, Van Golde LM, Haagsman HP. Localization and functions of SP-A and SP-D at mucosal surfaces. Pediatr Pathol Mol Med 2001; 20: 319-339.
41. Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, Van Golde LM. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990; 2: 91-98.
42. Gilliard N, Heldt GP, Loredo J, Gasser H, Redl H, Merritt TA, Spragg RG. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties. J Clin Invest 1994; 93: 2608-2615.
43. Crim C, Longmore WJ. Sublethal hydrogen peroxide inhibits alveolar type II cell surfactant phospholipid biosynthetic enzymes. Am J Physiol 1995; 268: L129-135.
44. Viuff B, Aasted B, Alexandersen S. Role of alveolar type II cells and of surfactant-associated protein C mRNA levels in the pathogenesis of respiratory distress in mink kits infected with Aleutian mink disease parvovirus. J Virol 1994; 68: 2720-2725.
45. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256.
46. Walmrath D, Gunther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F, Seeger W. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996; 154: 57-62.
47. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999; 282: 54-61.
48. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000; 284: 43-44.
49. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99: 944-952.
50. Ricard JD, Dreyfuss D, Saumon G. Production of inflammatory cytokines in ventilator-induced lung injury: A reappraisal. Am J Respir Crit Care Med 2001; 163: 1176-1180.
51. Verbrugge SJ, Uhlig S, Neggers SJ, Martin C, Held HD, Haitsma JJ, Lachmann B. Different ventilation strategies affect lung function but do not increase tumor necrosis factor-alpha and prostacyclin production in lavaged rat lungs in vivo. Anesthesiology 1999; 91: 1834-1843.
52. Chiumello D, Pristine D, Slutsky AS. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160: 109-116.
53. Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR, Nelson S. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 1994; 149: 1107-1111.
54. Uhlig S. Ventilation-induced lung injury and mechanotransduction: Stretching it too far? Am J Physiol Lung Cell Mol Physiol 2002: 282: L892-896.
55. Haitsma JJ, Uhlig S, Lachmann U, Verbrugge SJ, Poelma DLH, Lachmann B. Exogenous surfactant reduces ventilator-induced decompartmentalization of tumor necrosis factor-alpha in absence of positive end-expiratory pressure. Intensive Care Med 2002; 28: 1131-1137.
56. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989; 159: 189-194.
57. Ghofrani HA, Rosseau S, Walmrath D, Kaddus W, Kramer A, Grimminger F, Lohmeyer J, Seeger W. Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. Am J Physiol 1996; 270: L62-68.
58. Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, Deschenes M, Trouillet JL, Aubier M. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994; 150: 710-716.
59. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med, 1999; 27: 304-312.
60. Kawano T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, Bryan AC. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 1987; 62: 27-33.
61. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, Chevrolet JC. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998; 275: L1040-1050.
62. Vlahakis NE, Schroeder MA, Limper AH, Hubmayr RD. Stretch induces cytokine release by alveolar epithelial cells in vitro. Am J Physiol 1999; 277: L167-173.
63. Mourgeon E, Isowa N, Keshavjee S, Zhang X, Slutsky AS, Liu M. Mechanical stretch stimulates macrophage inflammatory protein-2 secretion from fetal rat lung cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L699-706.
64. Verbrugge SJ, De Jong JW, Keijzer E, Vazquez De Anda G, Lachmann B. Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury. Crit Care Med 1999; 27: 779-783.
65. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 1997; 155: 479-484.
66. Dos Santos CC, Slutsky AS. Mechanisms of ventilator-induced lung injury: A perspective. J Appl Physiol 2000; 89: 1645-1655.
67. Liu M, Tanswell AK, Post M. Mechanical force-induced signal transduction in lung cells. Am J Physiol 1999; 277: L667-683.
68. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869.
69. Uhlig U, Haitsma JJ, Goldmann T, Poelma DL, Lachmann B, Uhlig S. Ventilation-induced activation of the mitogen activated protein kinase pathway. Eur Resp J 2002; 20: 946-956.
70. Held HD, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappa B and is blocked by steroids. Am J Respir Crit Care Med 2001; 163: 711-716.
71. Von Bethmann AN, Brasch F, Muller KM, Wendel A, Uhlig S. Prolonged hyperventilation is required for release of tumor necrosis factor alpha but not IL-6. Appl Cardiopulm Pathol 1996; 6: 171-177.
72. Von Bethmann AN, Brasch F, Nusing R, Vogt K, Volk HD, Muller KM, Wendel A, Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998; 157: 263-272.
73. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
74. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1037-1050.
75. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996; 24: 1285-1292.
76. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16: 372-377.
77. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondejar E, Clementi E, Mancebo J, Factor P, Matamis D, Ranieri M, Blanch L, Rodi G, Mentec H, Dreyfuss D, Ferrer M, Brun-Buisson C, Tobin M, Lemaire F. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998; 158: 1831-1838.
78. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P, Jr., Wiener CM, Teeter JG, Dodd-o JM, Almog Y, Piantadosi S. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27: 1492-1498.
79. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, Mazer CD, McLean RF, Rogovein TS, Schouten BD, Todd TR, Slutsky AS. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 1998; 338: 355-361.
80. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347-354.
81. De Durante G, Del Turco M, Rustichini L, Cosimini P, Giunta F, Hudson LD, Slutsky AS, Ranieri VM. ARD-SNet lower tidal volume ventilatory strategy may generate intrinsic positive end-expiratory pressure in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 165: 1271-1274.
82. Lee CM, Neff MJ, Steinberg KP, Ranieri VM, Slutsky AS, Hudson LD. Effect of low tidal volume ventilation on intrinsic PEEP in patients with acute lung injury. Am J Respir Crit Care Med 2001; 163: A765.
83. Suchyta M, Morris AH, Thompson T, for the NIH/ARDS network. Attributes and outcomes of randomized vs. excluded patients in ALI/ARDS clinical trials. Am J Respir Crit Care Med 2000; 161: A210.
84. Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE, Benito S, Epstein SK, Apezteguia C, Nightingale P, Arroliga AC, Tobin MJ. Characteristics and outcomes in adult patients receiving mechanical ventilation: A 28-day international study. JAMA 2002; 287: 345-355.
85. Esteban A, Anzueto A, Alia I, Gordo F, Apezteguia C, Palizas F, Cide D, Goldwaser R, Soto L, Bugedo G, Rodrigo C, Pimentel J, Raimondi G, Tobin MJ. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med 2000; 161: 1450-1458.
86. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European Consensus conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994; 9: 72-81.
87. Ferring M, Vincent JL. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J 1997; 10: 1297-1300.
88. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-647.
89. Chollet-Martin S, Montravers P, Gibert C, Elbim C, Desmonts JM, Fagon JY, Gougerot-Pocidalo MA. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993; 61: 4553-4559.
90. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154: 602-611.
91. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F, II, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164: 1896-1903.
92. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-1314.
93. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997; 111: 1306-1321.
94. Roumen RM, Hendriks T, Van Der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, Van Der Meer JW, Goris RJ. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218: 769-776.
95. Vincent JL. New therapies in sepsis. Chest 1997; 112: 330S-338S.
96. Fisher CJ, Jr., Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334: 1697-1702.
97. Wrigge H, Zinserling J, Stuber F, Von Spiegel T, Hering R, Wetegrove S, Hoeft A, Putensen C. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology 2000; 93: 1413-1417.
98. Rimensberger PC, Pache JC, McKerlie C, Frndova H, Cox PN. Lung recruitment and lung volume maintenance: A strategy for improving oxygenation and preventing lung injury during both conventional mechanical ventilation and high-frequency oscillation. Intensive Care Med 2000; 26: 745-755.
99. Rimensberger PC, Cox PN, Frndova H, Bryan AC. The open lung during small tidal volume ventilation: Concepts of recruitment and "optimal" positive end-expiratory pressure. Crit Care Med 1999; 27: 1946-1952.
100. Hartog A, Vazquez De Anda GF, Gommers D, Kaisers U, Verbrugge SJ, Schnabel R, Lachmann B. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation in a model of acute lung injury. Br J Anaesth 1999; 82: 81-86.
101. Vazquez De Anda GF, Hartog A, Verbrugge SJ, Gommers D, Lachmann B. The open lung concept: Pressure-controlled ventilation is as effective as high-frequency oscillatory ventilation in improving gas exchange and lung mechanics in surfactant-deficient animals. Intensive Care Med 1999; 25: 990-996.
102. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992; 18: 319-321.